Press release: Government to publish plan for an independent fisheries policy

A blueprint for a sustainable and profitable fishing industry that will regenerate coastal communities and support future generations of fishermen will be set out today.

Outside the EU, the UK will be an independent coastal state and will regain control of our waters and natural resources, as well as the flexibility to negotiate with other countries and ensure stocks are fished sustainably.

The Fisheries White Paper – ‘Sustainable Fisheries for Future Generations’ – will chart our course for managing fisheries after Brexit. It will outline how powers to be proposed in the Fisheries Bill, which will be introduced in this session of Parliament, will give the UK full control of its waters and the ability to set fishing opportunities such as quota.

In particular the paper will set out how, as an independent coastal state, the UK will have the opportunity to move towards a fairer share of fishing opportunities – overhauling the current system where UK fishermen have received a poor deal that is based on fishing patterns from the 1970s. EU Member States currently land around eight times as much fish in UK waters than the UK does in EU Member States’ waters.

It will also propose a suite of measures to improve the sustainability of the fishing industry, supporting the next generation of fishermen while protecting our precious marine environment.

Prime Minister Theresa May said:

As an island nation our fishing industry is the lifeblood of coastal communities around the UK.

I have been clear that when we leave the EU we will take back control of our waters, while ensuring we don’t see our fishermen unfairly denied access to other waters.

The plans set out today demonstrate the bright future in store as we build UK fishing industry for future generations by putting the importance of a healthy marine environment at its heart.

Environment Secretary Michael Gove said:

Leaving the EU creates a sea of opportunity for our fishing industry. Outside the Common Fisheries Policy we can take back control of our waters and revitalise our coastal communities.

We will be able to put in place our own systems, becoming a world leader in managing our resources while protecting the marine environment.

We will work closely with everyone who has an interest in this important industry to make the most of this historic opportunity.

While the UK will continue to abide by Common Fisheries Policy rules during the implementation period, from 2020 we will be negotiating access to waters and fishing opportunities as an independent coastal state.

The white paper will set out a number of methods to explore fairer allocation of fishing opportunities, such as zonal attachment – which is based on distribution of fish stocks, rather than historical data.

Sitting at the heart of the white paper will be the UK government’s commitment to sustainable fisheries, including ending the wasteful discarding of fish and making clear vessels will only be allowed to fish in our waters if they adhere to our high sustainability standards.

The paper will also commit to publishing an annual statement setting out the health of fish stocks and based on the latest scientific evidence. If stocks are struggling, the four UK fisheries Administrations will work together to put in place a comprehensive recovery plan to restore them to healthy levels.

Likewise, the paper will outline a new approach to tackling ‘choke species’– one of the biggest challenges facing the fishing sector and which occurs when fishermen have used up their quota for a specific stock. As fishermen cannot target a certain area for risk of accidentally catching the exhausted stock, they either have to stop fishing or risk breaking the law if they land the extra stock.

The white paper will propose two new approaches in England: a reserve of quota that could be used to offset choke species, coupled with a new scheme to help fishermen unable to find quota to set against their catch.

And, as set out in its 25 Year Environment Plan, the government will pursue an ecosystem approach to fisheries management that will minimise impacts on non-commercial species and the marine environment.

Barrie Deas, CEO of the National Federation of Fishermen’s Organisation, said:

Today the Government has presented a broad vision for post-Brexit fisheries that is clear and cogent – and importantly, is aligned with international law. I am sure that it will attract wide support across the industry and Parliament.

Outside the EU, the UK will be an independent coastal state and this will provide the basis to rebalance quota shares and implement effective and adaptive management measures for our fisheries.

We are pleased a partnership with the fishing industry is at the heart of the Government’s approach. There is much to do and we look forward to working within this framework of cooperation.

Scottish Fishermen’s Federation Chief Executive Bertie Armstrong said:

The white paper enshrines the important elements that we have been arguing for to forge a sustainable future for our industry: allowing the UK to become an independent coastal state, to take charge of who catches what where and to resist any and all attempts to link access to our waters to access to EU markets.

Of course, there is a long way to go, and we now need our governments to show real backbone in the Brexit negotiations to ensure that these aspirations become reality.

Our approach will benefit the whole of the UK. The UK government will continue to work with the Devolved Administrations to develop a new UK framework for fisheries management, which will maximise their power to manage their fisheries while maintaining the overall coherence of the UK’s approach. It will also ensure compliance with international obligations to manage our shared resources sustainably.

We do not yet know the outcome of the UK’s negotiations to withdraw from the EU or on a future economic partnership, and the white paper will be clear that market access for fisheries products is separate to the question of fishing opportunities and access to waters.
Access to waters and fishing opportunities will be negotiated on an annual basis. This is consistent with the approach to fisheries taken by other coastal states including Norway.

Interested parties will now be invited to share their views on proposals outlined in the white paper during a 10 week consultation.




News story: Varuna report and flyer published

MAIB’s report on a man overboard from the creel boat Varuna on 20 November 2017 with loss of 1 life, is now published.

The report contains details of what happened and subsequent actions taken: read more.

A safety flyer to the fishing industry summarising the accident and detailing the safety lessons learned, has also been produced.

Press enquiries




News story: Medicinal cannabis review part 2 commissioned

Home Secretary Sajid Javid has today commissioned part 2 of the review into cannabis-related medicinal products, after the Chief Medical Officer concluded there is evidence of therapeutic benefit for some conditions.

Professor Dame Sally Davies, Chief Medical Officer and Chief Medical Advisor for the UK government, examined existing research into the therapeutic and medicinal benefits of cannabis-related medicinal products. Her report, which formed part 1 of the government review announced on 19 June, has now been published.

Commissioned today, the second part of the review will be completed by the Advisory Council on the Misuse of Drugs (ACMD). As part of this work the ACMD will advise on whether cannabis-related medicinal products should be rescheduled within 3 weeks.

Fresh look

Home Secretary Sajid Javid said:

Recent cases involving sick children made it clear to me that we needed to take a fresh look at the scheduling of cannabis-related medicinal products.

I would like to thank the Chief Medical Advisor for her initial review and have now asked my independent advisory committee to commence the second stage of this process.

When I have received its advice I will consider what next steps need to be taken.

The results from the Chief Medical Advisor’s report has advised that all cannabis-related medicinal products should be considered in part 2 of the review.

The government has absolutely no plans to legalise cannabis. Recreational use of cannabis will remain illegal and the penalties for unauthorised supply and possession will remain unchanged.

Therapeutic benefits

Chief Medical Advisor for the UK government Professor Dame Sally Davies said:

There is clear evidence from highly respected and trusted research institutions that some cannabis based medicinal products have therapeutic benefits for some medical conditions.

As Schedule 1 drugs by definition have little or no therapeutic potential, it is therefore now clear that from a scientific point of view keeping cannabis-based medicinal products in Schedule 1 is very difficult to defend.

Let me be emphatic – this report does not look at recreational cannabis use and does not endorse or condone recreational use. There is well-established evidence on the potential harm of recreational cannabis use. This is about helping patients, in exceptional circumstances, get access to treatment which could work.

Measures

This review forms part of a series of measures announced by the Home Secretary, including the launch of an expert panel who will consider individual applications from senior clinicians to prescribe cannabis-related medicinal products.

There are currently 8 members of the expert panel, which was launched on 27 June.

Chair: Dr Michael McBride – Chief Medical Officer for Northern Ireland

Members:

  • Dr Clare Gerada, MBE – GP and former chair, Royal College of General Practitioners
  • Professor Martin Kirkpatrick – Consultant Paediatric Neurologist, Scotland
  • Dr Jenny Harries, OBE – Deputy Medical Director and Regional Director South for Public Health England
  • Dr Jackie Cornish, OBE – National Clinical Director Children, Young People and Transition to Adulthood in NHS England
  • Professor Tom Walley, CBE – Professor of Clinical Pharmacology at Liverpool University and Director of the NIHR Health Technology Assessment Programme
  • Professor Finbar O’Callaghan – Professor of Paediatric Neuroscience at the UCL GOS Institute of Child Health and (Hon) Consultant Paediatric Neurologist at Great Ormond Street Hospital
  • Andrew Evans (non-voting observer) – Chief Pharmacist, Wales



News story: Medicinal cannabis review part 2 commissioned

Home Secretary Sajid Javid has today commissioned part 2 of the review into cannabis-related medicinal products, after the Chief Medical Officer concluded there is evidence of therapeutic benefit for some conditions.

Professor Dame Sally Davies, Chief Medical Officer and Chief Medical Advisor for the UK government, examined existing research into the therapeutic and medicinal benefits of cannabis-related medicinal products. Her report, which formed part 1 of the government review announced on 19 June, has now been published.

Commissioned today, the second part of the review will be completed by the Advisory Council on the Misuse of Drugs (ACMD). As part of this work the ACMD will advise on whether cannabis-related medicinal products should be rescheduled within 3 weeks.

Fresh look

Home Secretary Sajid Javid said:

Recent cases involving sick children made it clear to me that we needed to take a fresh look at the scheduling of cannabis-related medicinal products.

I would like to thank the Chief Medical Advisor for her initial review and have now asked my independent advisory committee to commence the second stage of this process.

When I have received its advice I will consider what next steps need to be taken.

The results from the Chief Medical Advisor’s report has advised that all cannabis-related medicinal products should be considered in part 2 of the review.

The government has absolutely no plans to legalise cannabis. Recreational use of cannabis will remain illegal and the penalties for unauthorised supply and possession will remain unchanged.

Therapeutic benefits

Chief Medical Advisor for the UK government Professor Dame Sally Davies said:

There is clear evidence from highly respected and trusted research institutions that some cannabis based medicinal products have therapeutic benefits for some medical conditions.

As Schedule 1 drugs by definition have little or no therapeutic potential, it is therefore now clear that from a scientific point of view keeping cannabis-based medicinal products in Schedule 1 is very difficult to defend.

Let me be emphatic – this report does not look at recreational cannabis use and does not endorse or condone recreational use. There is well-established evidence on the potential harm of recreational cannabis use. This is about helping patients, in exceptional circumstances, get access to treatment which could work.

Measures

This review forms part of a series of measures announced by the Home Secretary, including the launch of an expert panel who will consider individual applications from senior clinicians to prescribe cannabis-related medicinal products.

There are currently 8 members of the expert panel, which was launched on 27 June.

Chair: Dr Michael McBride – Chief Medical Officer for Northern Ireland

Members:

  • Dr Clare Gerada, MBE – GP and former chair, Royal College of General Practitioners
  • Professor Martin Kirkpatrick – Consultant Paediatric Neurologist, Scotland
  • Dr Jenny Harries, OBE – Deputy Medical Director and Regional Director South for Public Health England
  • Dr Jackie Cornish, OBE – National Clinical Director Children, Young People and Transition to Adulthood in NHS England
  • Professor Tom Walley, CBE – Professor of Clinical Pharmacology at Liverpool University and Director of the NIHR Health Technology Assessment Programme
  • Professor Finbar O’Callaghan – Professor of Paediatric Neuroscience at the UCL GOS Institute of Child Health and (Hon) Consultant Paediatric Neurologist at Great Ormond Street Hospital
  • Andrew Evans (non-voting observer) – Chief Pharmacist, Wales



Press release: UK steps up fight against Ebola following outbreak in Democratic Republic of Congo

The UK is backing the World Health Organisation’s (WHO’s) Regional Preparedness Plan to support nine countries at high risk of receiving cases of Ebola from their neighbour, the Democratic Republic Congo (DRC).

UK aid’s £1.5m of support will enable WHO to support countries with prevention, detection and containment of Ebola and other deadly diseases. It will also help important work being done at the community level, such as working with traditional healers, health workers and religious leaders around issues including safe and dignified burials. This will lead to an increased number of referrals of those with symptoms in harder to reach areas.

This new funding will help stop the immediate spread of the current DRC outbreak as well as build longer term resilience and follows significant support already committed by the International Development Secretary Penny Mordaunt in May. To date, the UK response has helped to stabilise the outbreak, but the threat of it spreading to other countries remains.

Minister for Africa, Harriett Baldwin said:

The UK continues to act decisively to stop this outbreak of Ebola, an horrific contagious disease which has the potential to cause devastating loss of life.

By supporting the WHO’s Regional Preparedness Plan, UK aid will help to scale up preparedness to ensure sustainability. We are not just waiting for the next outbreak to come along, but are actively working in partnership around the world to strengthen health systems. This is keeping us all safe from current and future global health emergencies.

The UK has the resources and know-how to help contain the spread of epidemics, but there is still work to do. Outbreaks are inevitable but epidemics are preventable.

Dr Ibrahima-Soce Fall, WHO Regional Emergencies Director, said:

Investing in preparedness is crucial to keep the world safe from Ebola. WHO is grateful for this additional funding from UK aid, which will support nine countries to better prevent, detect and respond to this deadly virus.

The UK continues to be a global leader in the fight against deadly diseases like Ebola and support to WHO reform in Africa has helped bring about a swifter and better-coordinated response to the outbreak in the DRC, a sharp contrast to the 2014 Ebola outbreak in Sierra Leone.

Notes to Editors

  • WHO’s Regional Preparedness and Readiness Plan aims to fill gaps identified by recent assessments. The estimated budget for the plan (June 2018 – February 2019) is US$15.5m over nine months. The plan is divided into two phases of priority actions. Phase I will be implemented in the next three months and will bolster operational readiness should there be any importation of Ebola cases. Phase II will look at the scale up of preparedness actions to ensure sustainability over the longer term.

  • This £1.5 million of new funding support is taken from DFID’s Crisis Reserve, and is being provided immediately to the World Health Organisation’s response plan for at least the next three months.

  • It comes after a previous £5 million support was provided to the World Health Organisation’s response plan in May 2018.

  • The Crisis Reserve funding is in addition to £1 million which DFID made available from its joint research initiative on epidemic preparedness with Wellcome. Wellcome has also made a further £2 million available to deal with the Ebola outbreak, which is being used to help roll out the vaccine campaign.

  • The UK’s response to Ebola in 2014 represented a great success in preventing the spread of a killer disease that threatened to reach 1.4 million cases. However, it came at significant cost to the UK taxpayer and African economies which lost at least $1.6 billion. Following previous DFID programmes (Regional Preparedness Programme and the Regional Malaria Programme, notably) the new Tackling Deadly Diseases in Africa Programme (TDDAP) aims to save lives and reduce the impact of disease outbreaks on African populations. This includes support to the reform of WHO in the Africa region, where it is already showing progress through swifter, better-coordinated outbreak responses in the DRC and Madagascar.

  • Investing in health systems early is important and good value for money, because it enhances the world’s ability to prevent epidemics, rather than reacting to the next crisis. Evidence suggests that for every £1 invested in preparation a £2 return can be achieved in terms of savings on future spending and investments.

  • Public Health England has assessed the risk of this outbreak to the UK as negligible to very low.

General media queries

Follow the DFID Media office on Twitter – @DFID_Press